Re-appointment of Mr. Siddhant Kothari (08620559), as a Whole Time Director, subject to approval of members at the ensuing 35th AGM.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kothari Fermentation & Biochem reported weak Q1 FY26 results, swinging to a net loss of ₹112.46 lakhs from a profit of ₹105.13 lakhs in Q4 FY25 and ₹109.78 lakhs in Q1 FY25. Revenue from operations fell to ₹2,375.31 lakhs, down from ₹2,635.52 lakhs a year ago, with EPS turning negative at ₹(0.75). The board approved the appointment of M/s Priyanka Saxena & Associates as Secretarial Auditor for 5 years and the 35th AGM on September 30, 2025. Independent Director Dr. Rajiv Agarwal resigned citing personal preoccupation, and Mr. Varun Kumar was appointed as a new Independent Director. Promoter family member Mr. Siddhant Kothari (son of Chairman & MD Pramod Kumar Kothari) was re-appointed as Whole-Time Director for the period August 29, 2025 to March 31, 2030.
Negative near-term sentiment likely due to the sharp swing from profit to loss and ~10% YoY revenue decline, while board continuity is preserved with promoter family re-appointment and a new independent director filling the casual vacancy.